Serum CEA levels are positively associated with advanced disease and tumor recurrence in resected NSCLC.56, 57, 58 Despite this well‐known association, there are few studies on the relationship between serum levels of CEA and brain metastases in advanced NSCLC. The gene discussed is CEACAM5; the disease is non-small cell lung carcinoma.